Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |